Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …

The pathogenesis of Coronavirus disease 2019 is still obscure and the need for exploration
of possible mechanisms to suggest drugs based on knowledge should never be delayed. In …

Introduction Ibuprofen disappeared from the pharmacy shelves during the 2019 coronavirus
(COVID-19) pandemic. However, a while later, information circulated that ibuprofen should …

The SARS-CoV-2 coronavirus has led to a pandemic with millions of people affected. The
present study finds that risk-factors for severe COVID-19 disease courses, ie male sex, older …

Objectives: This study aimed at exploring the impact of the COVID-19 pandemic on
pharmacological and physical/psychological treatments of CP. Methods: A Pan-Canadian …

COVID-19 pandemic is posing an unprecedented sanitary threat: antiviral and host-directed
medications to treat the disease are urgently needed. A great effort has been paid to find …

At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was
speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to …

Coronaviruses are a large family of viruses that are known to cause respiratory tract
infections ranging from colds to more severe diseases, such as Middle East Respiratory …

Purpose Conflicting information on potential benefits of drugs as well as reports on
hypothetical harm of commonly used drugs in COVID‐19 treatment have challenged …

During the COVID-19 pandemic, a correspondence, published at the Lancet Respiratory
Medicine, that linked angiotensin-converting enzyme inhibitors, angiotensin receptor …